4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Jacabio reports pre-clinical data for JAB-23E73 pan-KRAS inhibitor at international conference
Orion secures exclusive commercial licence for Abzena cancer antibody
ACM Biolabs reports ACM-CpG Phase 1 study findings in tumour treatment
Galera Therapeutics sells dismutase mimetics portfolio to Biossil in USD108.5m agreement
BD launches IVDR-certified self-collection solution to expand global access to HPV testing
Ipsen to acquire French biotech ImCheck Therapeutics in deal worth up to EUR1billion
Terns Pharmaceuticals reports topline 12-week data from Phase 2 trial of TERN-601 in obesity
Alligator Bioscience granted US patent for ATOR-4066 bispecific antibody
Citius Oncology and McKesson sign US distribution agreement for LYMPHIR
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
Merck reports long-term survival benefits of Keytruda in non-small cell lung cancer